Active	Status	Sponsor type	Region	Phase	Filter
11 Active 5 Inactive 16 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

11 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Wu, Hao
NCT04667299: Bismuth-Metronidazole Triple Therapy for H. Pylori First-line Treatment	Recruiting	4	270	RoW	Rabeprazole, Bismuth potassium citrate, Metronidazole, Amoxicillin	Shanghai Zhongshan Hospital	Helicobacter Pylori Infection	11/21	12/21
NCT05014685: PPI-amoxicillin for H. Pylori Treatment	Recruiting	4	732	RoW	Rabeprazole, Bismuth potassium citrate, Metronidazole, Amoxicillin	Shanghai Zhongshan Hospital	Helicobacter Pylori Infection	12/22	12/22
NCT05018923: Tetracycline Versus Doxycycline for HP Rescue Therapy	Recruiting	4	242	RoW	Rabeprazole, Bismuth potassium citrate, Metronidazole, Doxycycline, Tetracycline	Shanghai Zhongshan Hospital	Helicobacter Pylori Infection	12/22	12/22
NCT05023577: Antibiotic Combination for H. Pylori Eradication in Penicillin-allergic Patients	Recruiting	4	504	RoW	Rabeprazole, Bismuth potassium citrate, Metronidazole, Clarithromycin, Levofloxacin	Shanghai Zhongshan Hospital	Helicobacter Pylori Infection	12/22	12/22
NCT05061732: Helicobacter Pylori Eradication and Follow-up	Recruiting	4	4447	RoW	Rabeprazole, Bismuth potassium citrate, Metronidazole, Clarithromycin, Levofloxacin, Amoxicillin, Doxycycline, Tetracycline	Shanghai Zhongshan Hospital	Helicobacter Pylori Infection	06/26	06/26
TQB2102-II-03, NCT06496490: A Clinical Trial of TQB2102 for Injection in Non-small Cell Lung Cancer With HER2 Gene Abnormality	Recruiting	2	270	RoW	TQB2102 for injection, TQB2102 for injection combined with Benmelstobart injection	Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.	Non-Small Cell Lung Cancer	10/25	02/26
NCT04592315: A Study to Assess the Safety, Tolerability and Pharmacokinetics of Lipovirtide in HIV-infected Patients	Completed	1	46	RoW	Lipovirtide Injection	Shanxi Kangbao Biological Product Co., Ltd., Cancer Institute and Hospital, Chinese Academy of Medical Sciences	HIV Infections	05/23	07/23
NCT05349968: Pharmacokinetics and Efficacy of Multiple Dosing of Lipovirtide for Injection in HIV-infected Patients	Completed	1	24	RoW	Lipovirtide for injection, nothing	Shanxi Kangbao Biological Product Co., Ltd., Cancer Institute and Hospital, Chinese Academy of Medical Sciences	HIV Infections	06/23	09/23
NCT05489055: Effects of Contrast Media Temperature on Image Quality and Clinical Adverse Events in Coronary CTA	Recruiting	N/A	500	RoW	Iopamidol	Chongqing Emergency Medical Center, Army Medical Center of PLA	Contrast Media Adverse Reaction	01/23	02/23
MERAOLIS, NCT05854043: Modified Enhanced Recovery After Oblique Lateral Interbody Fusion Surgery	Recruiting	N/A	96	RoW	Modified ERAS protocol, routine protocol	Xuanwu Hospital, Beijing	Lumbar Spondylosis, Lumbar Spinal Stenosis, Lumbar Disc Herniation	08/24	04/25
NCT06029764: Extended One-level Interbody Fusion for Adjacent Vacuum Phenomenon in Lumbar Degenerative Disc Disease	Recruiting	N/A	126	RoW	extended one-level interbody fusion	Xuanwu Hospital, Beijing	Adjacent Segment Degeneration	01/28	01/29
Wang, Xiuling
No trials found